Acemoglu D.,Johnson S. .2007 .Disease and Development: The Effect of Life Expectancy on Economic Growth. Journal of Political Economy, 115(6) : 925-985.
Akhtar G. J. I. J. o. H.,Science S. .2013 .Indian pharmaceutical industry: an overview. , : .
Barro R. J. J. A. o. e. .2013 .Health and economic growth [J]. Annals of Economics and Finance, 14(2) : 329-366.
Blake H. .2013 .a-history-of-eli-lilly-co/. , : .
Blanc L. .2015 .The European Pharmaceutical Industry in a Global Economy: what drives EU exports of pharmaceuticals? [B]. , 31 : .
Bloom D. E.,Canning D.,Sevilla J. .2003 .The Effect of Health on Economic Growth: A Production Function Approach. , 07(1) : 0-02.
Board P. S. A. S. .1992 .Definition and recognition of the elements of financial statements:. Australian Accounting Research Foundation [B]., : .
Lelia Cosmina,Van Voinea,H. L. Voinea .2017 .Nonmarket strategic management. London Routledge., : .
Cung N. H. J. A. i. S. S. R. J. .2020 .. World Economic, 7(6) : 12-28.
DANZON P. M. .1997 .Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU. International Journal of the Economics of Business, 4(3) : 301-322.
Danzon P. M.,Chao L.-W. .2000 .Cross-national price differences for pharmaceuticals: how large, and why. Journal of Health Economics, 6296(99) : 00039-9.
Danzon P. M.,Mulcahy A. W.,Towse A. K.,Economics Procurement. Health .2013 .Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and. , 24(2) : 238-252.
Díaz R. F.,Sanchez-Robles B. J. M. .2020 .Non-Parametric Analysis of Efficiency: An Application to the Pharmaceutical Industry. Quantitative Methods of Economics and Finance, 8(9) : 1522-1549.
Duxbury P.,Tuck E. J. N. M. I. P. .2008 .Pharmaceutical patents need a new lease of life. , 42 : .
Haq S. .2014 .-drug-shortage-feared-asconsignments-stuck-at-ports. , : .
Hayat D. K. .2012 .Merck Pharmaceuticals (Private) Limited [OL]. , : .
Hess A. M.,Rothaermel F. T. .2011 .When are assets complementary? star scientists, strategic alliances, and innovation in the pharmaceutical industry. Strategic Management Journal, 32(8) : 895-909.
Hickson K. J. R. o. I.,Wealth. K. J. R. o. I. .2014 .The GDP Value of Twentieth-Century Health Improvements in Developed Economies: Initial Estimates for England [B]. , 60(2) : 385-399.
Junaidi I. .2015 .No law to stop pharma companies from importing raw materials [OL]. , : .
Kamath Bharathi,G. Bharathi .2008 .Intellectual capital and corporate performance in Indian pharmaceutical industry. Journal of Intellectual Capital, 9(4) : 684-704.
Khan N. .2016 .Pharmaceutical industry of Pakistan. , : .
Kirim A. S. .1985 .Reconsidering patents and economic development: A case study of the Turkish pharmaceutical industry. World Development, 13(85) : 90006-3.
Kumah A. J. I. J. o. C. I. R. .2017 .Minimum wage compliance in developing countries among the informal sector workers in. Ghana [B], 3(04) : .
Langley P. C. .1996 .The November 1995 Revised Australian Guidelines for the Economic Evaluation of Pharmaceuticals. PharmacoEconomics, 9(4) : 00019053-352.
Lee J.-Y.,Hunt P. .2012 .Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines. The Journal of Law, Medicine & Ethics, 00660(2) : 1748-720x.
Leeflang R. L. I.,Klein-Hesselink D. J.,Spruit I. P. .1992 .Health effects of unemployment-I. Long-term unemployed men in a rural and an urban setting. Social Science & Medicine, 34(92) : 90294-z.
Greve J. .2008 .Healthcare in developing countries and the role of business: a global governance framework to enhance the accountability of pharmaceutical companies. Corporate Governance: The International Journal of Business in Society, 8(4) : 490-505.
Madrid Y.,Velásquez G.,Fefer E. J. R. P. d. S. P. .1998 .The economics of pharmaceuticals and health sector reform in the Americas. , 3 : 343-350.
Majumdar S.,Asgari B. .2017 .Performance Analysis of Listed Companies in the UAE-Using DEA Malmquist Index Approach. American Journal of Operations Research, 07(02) : 133-151.
Mubarik S.,Chandran V.,Devadason E. S. .2016 .Relational capital quality and client loyalty: firm-level evidence from pharmaceuticals. -2015-0030, 23(1) : 43-60.
MURATOĞLU G. J. J. o. Y. U. .2017 .Does pharmaceutical industry boost economic growth? A Competitiveness-related approach [J]. Journal of Economic Development, 12(48) : 296-314.
MURATOĞLU G.,Economy Y. J. J. o. E.,P. Y. J. J. o. E. .2016 .Determinants of export competitiveness: evidence from OECD manufacturing [J]. Journal of Economics and Political Economy, 3(1) : 111-118.
Nath S. D.,Islam S.,Saha A. K. .2015 .Corporate Board Structure and Firm Performance: The Context of Pharmaceutical Industry in Bangladesh. International Journal of Economics and Finance, 7(7) : .
Ofoegbu G. N.,Onodugo V. A. .2016 .Liquidity management and profit performance of pharmaceutical manufacturing firms listed in Nigeria Stock Exchange. International Journal of Management Sciences and Business Research, 28(7) : 141-162.
Mardani A.,Zavadskas E. K.,Streimikiene D.,Jusoh A.,Khoshnoudi M. .2016 .A comprehensive review of data envelopment analysis (DEA) approach in energy efficiency. Renewable and Sustainable Energy Reviews, 12 : 1298-1322.
Shewell P.,Migiro S. .2016 .Data envelopment analysis in performance measurement: a critical analysis of the literature. , 14(3) : 3-713.
Shin K.,Lee D.,Shin K.,Kim E. .2018 .Measuring the Efficiency of U.S. Pharmaceutical Companies Based on Open Innovation Types. Journal of Open Innovation: Technology, Market, and Complexity, 4(3) : .
Urias E. .2017 .The contribution of the Pharmaceutical Industry to the health status of the developing world. International Business and Management, 41 : 67.
Graf von der Schulenburg ,Hoffmann C. .2000 .Review of European guidelines for economic evaluation of medical technologies and pharmaceuticals. HEPAC Health Economics in Prevention and Care, 1(1) : 2-8.
Weinstei n ,Siegel J. E.,Gold M. R.,Kamlet M. S.,Russell L. B. J. J. .1996 .. Recommendations of the Panel on Costeffectiveness in Health and Medicine [J]. JAMA, 276(15) : 1253-1258.
Yesyurun P. J. E. J. o. M. .2021 .The Determinants Factor of Dividend Payout Ratio: an Empirical Study of Bank Buku IV in Indonesia. Journal of Management Sciences, 11(2) : 71-224.